Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.244
Delayed Data
As of May 25
 -0.0048 / -1.93%
Today’s Change
0.21
Today|||52-Week Range
0.68
-31.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues6.3M13.2M22.0M1.8M
 
 
 
 
 
Cost of Goods Sold1.6M1.7M2.2M3.7K
 
 
 
 
 
Depreciation And Amortization500.2K571.4K501.4K254.6K
 
 
 
 
 
 
Operating ExpensesGross Income4.2M11.0M19.3M1.6M
 
 
 
 
 
General Expenses31.2M28.3M21.5M14.3M
 
 
 
 
 
Research And Development16.8M12.8M8.9M4.5M
 
 
 
 
 
Total Operating Expenses33.3M30.5M24.2M14.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.0M-17.3M-2.2M-12.8M
 
 
 
 
 
Extraordinary Credit0.000.002.9M153.4K
 
 
 
Extraordinary Charge-4.6M-4.4M0.00-4.6M
 
 
 
 
Pre-Tax Equity Earnings-523.8K-305.3K-15.2K0.00
 
 
 
 
Interest Expense On Debt3.7M6.9M14.9M159.0K
 
 
 
 
 
Other Expenses72.8K26.8K-67.7K-739.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.7M-28.8M-14.3M-17.8M
 
 
 
 
 
Income Taxes0.00-436.1K0.00-4.1M
 
 
 
Minority Interest0.00-855.00-648.00-210.00
 
 
 
 
Preferred Dividend0.00-46.0K0.000.00
 
 
Discontinued Operations0.00758.6K0.00-490.8K
 
 
 
Extraordinary Items0.000.000.0089.2M
 
 
Net Income-35.7M-27.6M-14.3M-14.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS148.7M151.2M155.4M161.6M
 
 
 
 
 
Shares To Calculate EPS Diluted148.7M151.2M155.4M161.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.18-$0.09$0.45
 
 
 
 
 
EPS Diluted-$0.24-$0.18-$0.09-$0.09